These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1819705)
1. Production of platelet-activating factor by human normodense and hypodense eosinophils. Ojima-Uchiyama A; Masuzawa Y; Sugiura T; Waku K; Fukuda T; Makino S Lipids; 1991 Dec; 26(12):1200-3. PubMed ID: 1819705 [TBL] [Abstract][Full Text] [Related]
2. Comparison of platelet-activating factor-induced chemotaxis of normodense and hypodense eosinophils. Little MM; Casale TB J Allergy Clin Immunol; 1991 Aug; 88(2):187-92. PubMed ID: 1880319 [TBL] [Abstract][Full Text] [Related]
3. Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients. Shindo K; Koide K; Hirai Y; Sumitomo M; Fukumura M Thorax; 1996 Feb; 51(2):155-8. PubMed ID: 8711647 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the generation of platelet-activating factor and leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and by the calcium ionophore A23187: the effects of nedocromil sodium. Burke LA; Crea AE; Wilkinson JR; Arm JP; Spur BW; Lee TH J Allergy Clin Immunol; 1990 Jan; 85(1 Pt 1):26-35. PubMed ID: 2153720 [TBL] [Abstract][Full Text] [Related]
5. IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. Cromwell O; Wardlaw AJ; Champion A; Moqbel R; Osei D; Kay AB J Immunol; 1990 Dec; 145(11):3862-8. PubMed ID: 2246516 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils. Mabuchi K; Sugiura T; Ojima-Uchiyama A; Masuzawa Y; Waku K Biochem Int; 1992 May; 26(6):1105-13. PubMed ID: 1321621 [TBL] [Abstract][Full Text] [Related]
7. Increased hypodense eosinophils after activation with PAF-acether and calcium ionophore in asthmatic subjects. Agrawal DK; Sarmiento EU; Nabe M; Miyagawa H; Townley RG J Asthma; 1996; 33(4):213-9. PubMed ID: 8707776 [TBL] [Abstract][Full Text] [Related]
8. The pathophysiological roles of heterogeneous eosinophils in allergic rhinitis caused by house dust mites. Takagi S; Nishihira J; Koyama Y; Ishibashi T Biochem Mol Biol Int; 1995 Aug; 36(5):1045-56. PubMed ID: 7581000 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. Camussi G; Bussolino F; Salvidio G; Baglioni C J Exp Med; 1987 Nov; 166(5):1390-404. PubMed ID: 3119758 [TBL] [Abstract][Full Text] [Related]
10. Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis. Hilliquin P; Dulioust A; Gregoir C; Arnoux A; Menkés CJ Inflamm Res; 1995 Aug; 44(8):313-6. PubMed ID: 8581516 [TBL] [Abstract][Full Text] [Related]
11. Specific high affinity binding of platelet activating factor to intact human blood neutrophils and eosinophils. Korth RM Int Arch Allergy Immunol; 1996 Jun; 110(2):124-31. PubMed ID: 8645989 [TBL] [Abstract][Full Text] [Related]
12. Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model. Cluzel M; Undem BJ; Chilton FH J Immunol; 1989 Dec; 143(11):3659-65. PubMed ID: 2555414 [TBL] [Abstract][Full Text] [Related]
13. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. Tamura N; Agrawal DK; Townley RG J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892 [TBL] [Abstract][Full Text] [Related]
14. The presence of platelet-activating factor associated with eosinophil and/or neutrophil accumulations in the pleural fluids. Oda M; Satouchi K; Ikeda I; Sakakura M; Yasunaga K; Saito K Am Rev Respir Dis; 1990 Jun; 141(6):1469-73. PubMed ID: 2350088 [TBL] [Abstract][Full Text] [Related]
15. Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils. Triggiani M; Schleimer RP; Tomioka K; Hubbard WC; Chilton FH Immunology; 1992 Dec; 77(4):500-4. PubMed ID: 1493922 [TBL] [Abstract][Full Text] [Related]
16. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. Bozza PT; Yu W; Cassara J; Weller PF J Leukoc Biol; 1998 Oct; 64(4):563-9. PubMed ID: 9766638 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils. Remy E; Lenoir G; Houben A; Vandesteene C; Remacle J Biochim Biophys Acta; 1989 Sep; 1005(1):87-92. PubMed ID: 2505852 [TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor activates two distinct effector pathways in human eosinophils. Kato M; Kimura H; Motegi Y; Tachibana A; Minakami H; Morikawa A; Kita H J Immunol; 2002 Nov; 169(9):5252-9. PubMed ID: 12391244 [TBL] [Abstract][Full Text] [Related]
19. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Chanez P; Dent G; Yukawa T; Barnes PJ; Chung KF Eur Respir J; 1990 Oct; 3(9):1002-7. PubMed ID: 2289546 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. Kurihara K; Wardlaw AJ; Moqbel R; Kay AB J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]